Published in Biochim Biophys Acta on July 30, 2010
The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol (2013) 3.13
Glial influence on the blood brain barrier. Glia (2013) 1.12
Monoclonal antibodies in treatment of multiple sclerosis. Clin Exp Immunol (2014) 0.91
Interplaying factors that effect multiple sclerosis causation and sustenance. ISRN Neurol (2012) 0.89
MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a. J Neuroimmunol (2014) 0.82
Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis. Mult Scler (2014) 0.81
Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis. PLoS One (2013) 0.79
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis. J Neuroimmunol (2014) 0.78
Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients. Acta Neuropathol (2016) 0.75
High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients. Mol Cell Proteomics (2016) 0.75
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med (2008) 12.90
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol (2009) 3.35
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol (2010) 2.41
Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol (2008) 2.02
Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann Neurol (2010) 1.97
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol (2007) 1.88
Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Arch Neurol (2010) 1.61
Pediatric multiple sclerosis. Nat Rev Neurol (2009) 1.50
Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann Neurol (2014) 1.50
Retracted Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies. Mult Scler Int (2011) 1.26
Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med (2015) 1.18
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol (2012) 1.18
Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014. MMWR Morb Mortal Wkly Rep (2014) 1.10
Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol (2012) 1.04
Switching multiple sclerosis patients with breakthrough disease to second-line therapy. PLoS One (2011) 1.02
Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population. J Neuroophthalmol (2009) 1.01
Update on biomarkers in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm (2015) 0.96
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review. PLoS One (2013) 0.94
Pediatric multiple sclerosis. Neurol Clin (2011) 0.93
International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology (2013) 0.89
Clinical predictors of early second event in patients with clinically isolated syndrome. J Neurol (2009) 0.88
Precision medicine in chronic disease management: The multiple sclerosis BioScreen. Ann Neurol (2014) 0.87
Treatment of multiple sclerosis in children and adolescents. Expert Opin Pharmacother (2010) 0.85
Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling. J Neuroimmunol (2007) 0.84
Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis. Mult Scler (2011) 0.84
Does race matter for multiple sclerosis? Neurology (2010) 0.84
Relapse severity and recovery in early pediatric multiple sclerosis. Mult Scler (2011) 0.84
Pediatric multiple sclerosis. NeuroRx (2006) 0.84
Health-related quality of life is reduced in pediatric multiple sclerosis. Pediatr Neurol (2010) 0.83
EDSS variability before randomization may limit treatment discovery in primary progressive MS. Mult Scler (2012) 0.83
Pediatric multiple sclerosis. Curr Neurol Neurosci Rep (2008) 0.83
Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis. Neurosurgery (2012) 0.82
Association of multiple sclerosis susceptibility variants and early attack location in the CNS. PLoS One (2013) 0.81
Treatment adherence and transitioning youth in pediatric multiple sclerosis. Mult Scler Relat Disord (2014) 0.79
Challenges in the classification of pediatric multiple sclerosis and future directions. Neurology (2007) 0.78
Neuroprotection in multiple sclerosis: a therapeutic approach. CNS Drugs (2013) 0.78
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery. PLoS One (2013) 0.78
Therapeutic advances in pediatric multiple sclerosis. J Pediatr (2013) 0.78
Antibodies to potassium channels in multiple sclerosis. N Engl J Med (2012) 0.77
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. BMC Neurol (2013) 0.76
Humoral-targeted immunotherapies in multiple sclerosis. Neurotherapeutics (2013) 0.76
Interferon beta babies. Neurology (2005) 0.75
Improving outcomes in multiple sclerosis through early diagnosis and effective management. Prim Care Companion CNS Disord (2012) 0.75
Acute pathological laughter. Mov Disord (2005) 0.75
Editors' Welcome. Mult Scler Relat Disord (2017) 0.75
Editors' Welcome. Mult Scler Relat Disord (2017) 0.75
Editors' welcome. Mult Scler Relat Disord (2017) 0.75
Editors' Welcome. Mult Scler Relat Disord (2017) 0.75
Editors' Welcome. Mult Scler Relat Disord (2016) 0.75
Editors' Welcome. Mult Scler Relat Disord (2017) 0.75
Pediatric multiple sclerosis. Continuum (Minneap Minn) (2010) 0.75
Editors' Welcome. Mult Scler Relat Disord (2017) 0.75
Atypical cases of scleroderma en coup de sabre. J Child Neurol (2014) 0.75